AI-enabled drug discovery approach identified potentially game-changing treatment, which has been advanced from the lab bench to an FDA Orphan Drug Designation in record time| Wyss InstituteWyss Institute
Patient-matched Organ Chips mimicking the tumor microenvironment can effectively personalize chemotherapy selection in cancer patients| Wyss InstituteWyss Institute
By Alexandra Jirstrand (BOSTON) – The Wyss Institute at Harvard University, its Board of Directors, and Executive Leadership are pleased to announce that Natalie Artzi, Ph.D., has been appointed to a newly created position as Associate Institute Director of the Wyss Institute. In her new role, Artzi will work closely with the Wyss Founding Director...| Wyss Institute
This op-ed originally appeared in MedPage Today. By Donald Ingber, M.D., Ph.D. I was on the frontlines when COVID-19 hit and it felt like a surprise attack. Many academic research departments closed, but the Wyss Institute at Harvard, which I head, moved into high gear. We raced to develop new ways to manufacture nasal swabs,...| Wyss Institute